Indeed, we discovered that 23-HBA decreased the phosphorylation level of STAT6 protein in M2 macrophages, accompanied by a decrease in M2-related cytokine IL-10 secretion and an inhibition of STAT3/Bcl-2 signaling of cancer cells, resulting in a reduction in 5-FU resistance. The gene discussed is BCL2; the disease is cancer.